Company intelligence
VivoSim Labs, Inc.
Pharmaceutical services company providing testing of drugs and drug candidates in human 3D models of liver and intestine
About VivoSim Labs, Inc.
We are pioneering a unique set of therapeutic and drug profiling capabilities based on our revolutionary ability to 3D bioprint tissues that mimic key aspects of human biology and disease. We intend to fundamentally alter the drug discovery landscape by the development of novel therapies for disease which have a much higher chance of efficacy in the clinic focused on human primary cell 3D models of disease that more faithfully recapitulate disease processes. Learn more at www.organovo.com.
Verified activity
Signals from VivoSim Labs, Inc.
3 published signals
Presence & Recognition
VivoSim Labs, Inc. participated in the panel discussions
Reported by Arumugham (Ragoo) Raghunathan
Research & Knowledge
VivoSim Labs, Inc. published a post on designing robust recovery studies to de-risk your pipeline by incorporating predefined washout and recovery phases into repeat-dose 3D liver and intestinal models.
Reported by Arumugham (Ragoo) Raghunathan
Presence & Recognition
VivoSim Labs, Inc. announced that early bird pricing for the 2026 Annual Conference in NYC ends TODAY.
Reported by Arumugham (Ragoo) Raghunathan